首页> 美国卫生研究院文献>PLoS Computational Biology >Modeling antibiotic treatment in hospitals: A systematic approach shows benefits of combination therapy over cycling, mixing, and mono-drug therapies
【2h】

Modeling antibiotic treatment in hospitals: A systematic approach shows benefits of combination therapy over cycling, mixing, and mono-drug therapies

机译:在医院中对抗生素治疗进行建模:一种系统化的方法显示了联合治疗优于循环,混合和单药治疗的益处

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Multiple treatment strategies are available for empiric antibiotic therapy in hospitals, but neither clinical studies nor theoretical investigations have yielded a clear picture when which strategy is optimal and why. Extending earlier work of others and us, we present a mathematical model capturing treatment strategies using two drugs, i.e the multi-drug therapies referred to as cycling, mixing, and combination therapy, as well as monotherapy with either drug. We randomly sample a large parameter space to determine the conditions determining success or failure of these strategies. We find that combination therapy tends to outperform the other treatment strategies. By using linear discriminant analysis and particle swarm optimization, we find that the most important parameters determining success or failure of combination therapy relative to the other treatment strategies are the de novo rate of emergence of double resistance in patients infected with sensitive bacteria and the fitness costs associated with double resistance. The rate at which double resistance is imported into the hospital via patients admitted from the outside community has little influence, as all treatment strategies are affected equally. The parameter sets for which combination therapy fails tend to fall into areas with low biological plausibility as they are characterised by very high rates of de novo emergence of resistance to both drugs compared to a single drug, and the cost of double resistance is considerably smaller than the sum of the costs of single resistance.
机译:医院中的经验性抗生素治疗可采用多种治疗策略,但是,无论哪种策略最佳以及为什么,临床研究和理论研究都没有清晰的画面。在扩展其他人和我们的早期工作的基础上,我们提出了一种数学模型,该模型捕获了使用两种药物的治疗策略,即被称为循环,混合和联合治疗的多药疗法,以及使用任何一种药物的单药疗法。我们随机抽样一个较大的参数空间以确定确定这些策略成功或失败的条件。我们发现联合治疗往往优于其他治疗策略。通过使用线性判别分析和粒子群优化,我们发现,与其他治疗策略相比,决定组合疗法成功与否的最重要参数是感染敏感细菌的患者出现双药耐药的重新发生率和健身费用与双重抵抗有关。由于所有治疗策略均受到同等影响,通过外部社区收治的患者将双重耐药性输入医院的比率几乎没有影响。联合疗法失败的参数集往往会落入生物似然性较低的区域,因为它们的特点是与单一药物相比,从头出现两种药物的耐药率很高,并且双重耐药的成本大大小于单一电阻的成本总和。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号